To further investigate whether the adoptively transplanted CD8+ TRM cells could survive and remain in the brains of naïve recipient mice, we subsequently challenged the recipient mice with glioma cells on day 40 after adoptive CD8+ T cell transplantation. Here, CD8A is linked to central nervous system cancer.